On July 25, 2022, the State Food and Drug Administration approved the application for registration of new indications for the treatment of coronavirus pneumonia with Azovudine under emergency conditions for the treatment of adult patients with common new coronavirus pneumonia (COVID-19). ...
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
